Disodium aurothiomalate
Disodium aurothiomalate is a chemical compound with the formula AuSCH(CO2Na)CH2CO2Na.  In conjunction with its monoprotonated derivative, this coordination complex or closely related species are used to treat rheumatoid arthritis, under the tradename Myochrysine.  The thiomalate is racemic in most formulation.

# Structure
Disodium aurothiomalate is a polymer.  The salt CsNa2Au2T(TH) salt (T = thiomalate3-, TH = monoprotonated thiomalate2-) is related to disodium aurothiomalate but is easier to crystallise and characterise by X-ray crystallography.  The compound is polymeric with Au-S-Au-S... chains with succinoyl groups attached to the sulfur atoms.  The structure of the related drug Aurothioglucose is also polymeric with two-coordinate gold(I) centers.  In such compounds, the efficacy results from the compound in solution, the structures of such solution species are often poorly understood.  Medical texts sometimes suggest that free Au+ ions exist in this and related gold(I) compounds, but the Au-thiolate bonding is highly covalent and free gold ions do not exist in solution.  Whereas simple gold thiolates are lipophilic, the carboxylate substituents render disodium aurothiomalate soluble in water.
Sometimes classified as an organogold complex, disodium aurothiomalate contains no Au-C bonds, so it is not an organometallic compound in the formal sense.

# Mechanism of action
Unknown. In vitro experiments have shown that Au(I) can inhibit lymphocyte proliferation, lysosomal enzyme release, the release of reactive oxygen species from macrophages, and IL-1 production.
Gold salts can decrease the inflammation of the joint lining. This effect can prevent destruction of bone and cartilage. In former times gold salts were used as second-line drugs (used when the arthritis progressed in spite of antiinflammatory drugs). Nowadays such former "second-line" drugs are used from the beginning of therapy to inhibit joint erosion if possible.

# Side effects
Disodium aurothiomalate can cause photosensitive rashes, gastrointestinal disturbance, and kidney damage.

# Footnotes
-  Jump up to: 1.0 1.1 Shaw, III, C. F. (1999). "Gold-Based Therapeutic Agents". Chemical Reviews. 99: 2589600. doi:10.1021/cr980431o.CS1 maint: Multiple names: authors list (link) .mw-parser-output cite.citation{font-style:inherit}.mw-parser-output q{quotes:"\"""\"""'""'"}.mw-parser-output code.cs1-code{color:inherit;background:inherit;border:inherit;padding:inherit}.mw-parser-output .cs1-lock-free a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-limited a,.mw-parser-output .cs1-lock-registration a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-lock-subscription a{background:url("")no-repeat;background-position:right .1em center}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration{color:#555}.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration span{border-bottom:1px dotted;cursor:help}.mw-parser-output .cs1-hidden-error{display:none;font-size:100%}.mw-parser-output .cs1-visible-error{display:none;font-size:100%}.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registration,.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-right{padding-right:0.2em}
-  Bau, R. (1998). "Crystal Structure of the Antiarthritic Drug Gold Thiomalate (Myochrysine): A Double-Helical Geometry in the Solid State". Journal of the American Chemical Society. 120: 93801. doi:10.1021/ja9819763.